Renovaro closes $10M private placement of common stock and warrants at $1.4726/unit

Lunai Bioworks Inc.

Sold 6,421,256 units (1 share + 1/10 warrant) at $1.4726 each, raising ~$9.45M in cash and debt conversions.
Cash proceeds of $5.8M from one investor; $478k cash plus $3.19M note conversion from second; $66k cash plus $468k note from third.
Warrants exercisable at $1.4726 per share for 5 years, representing 10% dilution on exercised shares.
Net proceeds allocated for general corporate purposes.
CEO comments on potential future grants, loans, subsidies from US and European institutions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.